REGENERON PHARMACEUTICALS, INC.: revenue
| Value | {"amount": 6557600000, "concept": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "currency": "USD"} |
|---|---|
| Period | 2019-01-01 – 2019-12-31 |
| Status | current |
| Entity | REGENERON PHARMACEUTICALS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T08:39:09.179697+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/d5d0de09-050d-4cbb-8af4-21fc677ebad4
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001804220-21-000008Retrieved: 2026-08-19T08:39:09.179697+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0000872589/revenue/2019-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/d5d0de09-050d-4cbb-8af4-21fc677ebad4
History
- supersedes {"amount": 7863400000, "concept": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "currency": "USD"} (evidence 0001532176-20-000008)